Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 4
1992 6
1993 7
1994 21
1995 21
1996 25
1997 15
1998 18
1999 22
2000 24
2001 26
2002 21
2003 32
2004 33
2005 31
2006 30
2007 22
2008 35
2009 9
2010 24
2011 27
2012 16
2013 16
2014 20
2015 21
2016 13
2017 26
2018 14
2019 10
2020 8
2021 12
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

588 results

Results by year

Filters applied: . Clear all
Page 1
Role of the p16 tumor suppressor gene in cancer.
Liggett WH Jr, Sidransky D. Liggett WH Jr, et al. Among authors: sidransky d. J Clin Oncol. 1998 Mar;16(3):1197-206. doi: 10.1200/JCO.1998.16.3.1197. J Clin Oncol. 1998. PMID: 9508208 Review.
Mitochondrial subversion in cancer.
Chatterjee A, Dasgupta S, Sidransky D. Chatterjee A, et al. Among authors: sidransky d. Cancer Prev Res (Phila). 2011 May;4(5):638-54. doi: 10.1158/1940-6207.CAPR-10-0326. Cancer Prev Res (Phila). 2011. PMID: 21543342 Free PMC article. Review.
Cancer epigenetics: above and beyond.
Brait M, Sidransky D. Brait M, et al. Among authors: sidransky d. Toxicol Mech Methods. 2011 May;21(4):275-88. doi: 10.3109/15376516.2011.562671. Toxicol Mech Methods. 2011. PMID: 21495866 Free PMC article. Review.
Patient-derived xenografts as tools in pharmaceutical development.
Izumchenko E, Meir J, Bedi A, Wysocki PT, Hoque MO, Sidransky D. Izumchenko E, et al. Among authors: sidransky d. Clin Pharmacol Ther. 2016 Jun;99(6):612-21. doi: 10.1002/cpt.354. Epub 2016 Mar 9. Clin Pharmacol Ther. 2016. PMID: 26874468 Review.
p16(MTS-1/CDKN2/INK4a) in cancer progression.
Rocco JW, Sidransky D. Rocco JW, et al. Among authors: sidransky d. Exp Cell Res. 2001 Mar 10;264(1):42-55. doi: 10.1006/excr.2000.5149. Exp Cell Res. 2001. PMID: 11237522 Review.
DNA methylation markers in colorectal cancer.
Kim MS, Lee J, Sidransky D. Kim MS, et al. Among authors: sidransky d. Cancer Metastasis Rev. 2010 Mar;29(1):181-206. doi: 10.1007/s10555-010-9207-6. Cancer Metastasis Rev. 2010. PMID: 20135198 Review.
Epigenomics-based diagnostics.
Diamandis EP, Sidransky D, Laird PW, Cairns P, Bapat B. Diamandis EP, et al. Among authors: sidransky d. Clin Chem. 2010 Aug;56(8):1216-9. doi: 10.1373/clinchem.2010.148007. Epub 2010 May 14. Clin Chem. 2010. PMID: 20472819 No abstract available.
Emerging molecular markers of cancer.
Sidransky D. Sidransky D. Nat Rev Cancer. 2002 Mar;2(3):210-9. doi: 10.1038/nrc755. Nat Rev Cancer. 2002. PMID: 11990857 Review.
588 results